Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART (20 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
2 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
3 Recruiting Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
Conditions: Lymphoma-AIDS-Related;   Brain Neoplasm
Interventions: Drug: Methotrexate;   Drug: Rituximab;   Drug: Leucovorin
4 Recruiting Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
Conditions: Acute HIV Infection;   Antiretroviral Treatment Interruption
Intervention: Other: Treatment interruption
5 Recruiting Functional Cure Study of HIV-infected Patients
Condition: HIV
Intervention: Procedure: cART course
6 Recruiting Use of Incentives to Retain Drug Users in HIV Therapy
Condition: HIV Infection
Intervention: Other: monetary reinforcer
7 Recruiting Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)
Conditions: NVP Plasma Level;   NVP Related Mutation;   3TC Related Mutation
Intervention: Drug: AZT/3TC 2 weeks after delivery
8 Recruiting Reconstitution of HIV-specific Immunity Against HIV
Condition: HIV
Intervention: Other: HIV-specific CD8 cells
9 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
Intervention:
10 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution
11 Recruiting Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients
Conditions: HIV Seropositivity;   ART
Intervention: Dietary Supplement: VSL#3 sachets
12 Recruiting Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly
Conditions: HIV;   Tuberculosis
Interventions: Drug: Lopinavir/r will be supplied by NHSO/GPO;   Drug: Rifabutin
13 Recruiting Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Conditions: AIDS-Related Hodgkin Lymphoma;   AIDS-Related Non-Hodgkin Lymphoma;   HIV Infection;   Recurrent Hodgkin Lymphoma;   Recurrent Non-Hodgkin Lymphoma
Interventions: Biological: Gene-Modified HIV-Protected Hematopoietic Stem Cells;   Other: Laboratory Biomarker Analysis;   Other: Transplant Conditioning
14 Recruiting Body Image and Self-Care in HIV-Infected MSM
Conditions: Body Image Disturbance;   Medication Adherence
Interventions: Behavioral: Experimental Intervention;   Behavioral: TAU
15 Recruiting The Use of Leukapheresis to Support HIV Pathogenesis Studies
Condition: HIV
Intervention: Procedure: Leukapheresis
16 Recruiting Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
Condition: HIV-1 Infection
Intervention: Biological: HIV DNA
17 Recruiting Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial
Condition: HIV
Interventions: Drug: Nevirapine (NVP);   Drug: Zidovudine (ZDV);   Drug: Lamivudine (3TC)
18 Recruiting A Prospective Cohort of Children With HIV Infection
Condition: HIV Infections
Interventions: Drug: Zidovudine, Stavudine, Didanosine, Lamivudine;   Drug: Nevirapine, Efavirenz;   Drug: LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir
19 Recruiting AIDS 347: IL-6 Blockade in Treated HIV Infection
Condition: HIV Infections
Interventions: Drug: tocilizumab;   Drug: Placebo
20 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy

Study has passed its completion date and status has not been verified in more than two years.